Pathophysiology and Clinical Significance of Hypercalcemia

Hypercalcemia is defined as a total serum calcium concentration above the reference range. In healthy animals, calcium levels are tightly regulated by parathyroid hormone (PTH), vitamin D, and calcitonin. When these controls are disrupted, the body enters a state of mineral imbalance that can cause rapid tissue damage. Chronic elevation is particularly dangerous as it mimics signs of Hypoadrenocorticism and other endocrinopathies, making it a diagnostic challenge for veterinary clinicians.

The Role of Ionized Calcium

While total calcium is often measured, ionized calcium is the physiologically active form. It is this fraction that exerts the most significant impact on cellular function. When ionized calcium is high, it can induce significant clinical malaise, even if total calcium appears only marginally elevated.

Diagnostic Investigation and Clinical Presentation

Veterinarians approach hypercalcemia as a symptom of a primary underlying pathology. The diagnostic process often mirrors the investigation for Hyperadrenocorticism, requiring extensive metabolic screening and diagnostic imaging.

Imaging and Biochemical Markers

Physical examination alone rarely provides a definitive diagnosis. Instead, practitioners utilize:

  • Radiography and Ultrasound to look for occult neoplasia.

  • PTH and PTH-related protein (PTHrP) assays.

  • Renal panels to rule out secondary complications like Glomerulonephritis.

Etiology and Pathogenesis of Mineral Imbalance

Hypercalcemia typically arises from one of several distinct mechanisms, categorized by the source of the excess calcium.

Malignancy-Associated Hypercalcemia

Lymphoma and anal sac adenocarcinoma are frequent contributors to elevated calcium in dogs. These tumors secrete PTHrP, a protein that mimics the natural parathyroid hormone, causing the body to leach calcium from the bones and retain it in the bloodstream.

Granulomatous Disease and Endocrine Links

Inflammatory conditions or systemic fungal infections can lead to hypercalcemia through the production of vitamin D-like compounds. Additionally, endocrine diseases like Pheochromocytoma may present with concurrent electrolyte shifts. It is also important to differentiate hypercalcemia from the symptoms of Fanconi Syndrome, which affects renal tubular reabsorption.

Therapeutic Strategies and Management

Once the severity is established, treatment focuses on 'calciuresis'—increasing the excretion of calcium.

Fluid Therapy and Diuresis

Intravenous fluid therapy with saline is the cornerstone of emergency management. Sodium helps facilitate calcium excretion through the kidneys.

Advanced Pharmacological Intervention

When fluids are insufficient, veterinarians may prescribe bisphosphonates or calcitonin to inhibit bone resorption. In cases where liver involvement is suspected, providers must be cautious, as some medications can exacerbate symptoms associated with Fibrosing Liver Disease. Long-term dietary management, including low-calcium formulations, is often required, particularly if there is chronic renal compromise.